This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $8,295,059.00 to the Republic of Namibia Ministry of Health and Social Services over a 5-year period from September 30, 2024 to September 30, 2029. The funding supports comprehensive efforts to combat HIV/AIDS in Namibia through the President's Emergency Plan for AIDS Relief (PEPFAR). Key activities include HIV testing, prevention, treatment,...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to adapt and evaluate the effectiveness of the Comprehensive Adherence Resource and Empowerment Support (CARES) intervention to increase pre-exposure prophylaxis (PrEP) continuation and adherence among adolescent girls and young women in South Africa and Zimbabwe. The total funding amount is $710,187, with an award date of September 11, 2024 and an...
The Department of State Bureau of African Affairs awarded a $110,000 project grant to Treatment Advocacy And Litera CY Campaign to implement the COMMUNITY LED MONITORING TO IMPROVE QUALITY OF HIV CARE IN ZAMBIA THROUGH CLIENT FEEDBACK project from March 1, 2022 to December 30, 2022. Under this award, Treatment Advocacy And Litera CY Campaign will work to improve HIV care quality in Zambia by establishing a community-led monitoring program that gathers client feedback. The grant is part of the...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is providing $573,475 to The Botswana Harvard Health Partnership (BHP) to conduct a randomized trial evaluating the effect of integrating sexually transmitted infection (STI) testing with expanded pre-exposure prophylaxis (PrEP) options on PrEP use among pregnant women in Botswana. The study aims to...
The National Institute of Mental Health (NIMH) awarded a Project Grant under the Mental Health Research Grants (CFDA 93.242) program to The Washington University in the amount of $1,325,208 on August 9, 2024. The grant will fund a Sequential Multiple Assignment Randomized Trial (SMART) to assess different sequential combinations of strategies to return individuals with HIV treatment lapses to care and reengage them long-term in Zambia. The key products/services to be delivered include: Comparing...
This Project Grant award of $160,000 from the Department of State Bureau of African Affairs supports efforts by Adpp Angola under the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) Programs (CFDA 19.029) to prevent mother-to-child transmission of HIV in Angola. Key deliverables include strengthening HIV care and treatment at health facilities, increasing community engagement, and building clinical laboratory and supply chain infrastructure from August 6, 2021 to September 30, 2021....
This Project Grant award of $197,035 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year study to design and evaluate a community-based intervention to engage men who use alcohol and substances in HIV prevention services in rural South Africa. The primary objectives are to: 1) explore perceptions and preferences for HIV prevention services among men who frequent local bars (shebeens), 2) develop an intervention...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...
This Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $1,251,196 to the University of Washington to scale up an evidence-based Adolescent Transition Package (ATP) to support transitional care for youth living with HIV in Kenya. The project aims to compare two implementation strategies for scaling up the ATP: the standard Kenya Ministry of Health approach versus an enhanced strategy that incorporates...
This federal Project Grant award from the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) provides $998,850.00 to The RAND Corporation to conduct a study titled "Incentives and Reminders to Improve Long-Term Medication Adherence (INMIND)". The study aims to test the effectiveness of a behavioral economics-based intervention using daily reminder messages and small monthly incentives to help people living with HIV establish long-term...